All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experience

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33150782" target="_blank" >RIV/61989592:15110/15:33150782 - isvavai.cz</a>

  • Alternative codes found

    RIV/00098892:_____/15:#0000898

  • Result on the web

    <a href="http://dx.doi.org/10.4149/neo_2015_019" target="_blank" >http://dx.doi.org/10.4149/neo_2015_019</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.4149/neo_2015_019" target="_blank" >10.4149/neo_2015_019</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experience

  • Original language description

    Acute promyelocytic leukemia is a unique entity among acute leukemias. Introduction of all-trans retinoic acid and, subsequently, arsenic trioxide in its treatment has markedly improved treatment outcomes for this once frequently fatal disease. Improvedoutcomes have also been observed in elderly patients, including those in whom standard intensive therapy is contraindicated because of comorbidities. In our center, a total of 60 APL patients were treated in 1993-2013, of whom 9 were aged 60 or more years. Although most of them had significant comorbidities at the time of diagnosis, eight achieved complete remission. At the time of the analysis, six patients were alive and in long-term remission; two patients died of causes other than APL. The median follow-up was 59 months. Included is case report of a patient with a high comorbidity score whose treatment was markedly reduced and individualized. Our experience shows that, in APL patients a curative approach is generally tolerated and s

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)<br>S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Neoplasma

  • ISSN

    0028-2685

  • e-ISSN

  • Volume of the periodical

    62

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    SK - SLOVAKIA

  • Number of pages

    6

  • Pages from-to

    146-151

  • UT code for WoS article

  • EID of the result in the Scopus database